Literature DB >> 6712192

A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.

J Aicardi, F Goutières.   

Abstract

Eight infants developed a progressive disorder of the central nervous system with bilateral spasticity and dystonia, acquired microcephaly, and a rapid course toward profound deterioration and death. All the patients had abnormal cerebrospinal fluid with mild but persistent lymphocytosis. Computed tomography showed various combinations of bilateral symmetrical calcifications in the basal ganglia, progressive brain atrophy, and deep white matter hypodensities, the first two being present in all families but not in every individual patient. The disorder is familial and probably genetic in origin, although some features, especially the pleocytosis, may erroneously suggest an inflammatory condition.

Entities:  

Mesh:

Year:  1984        PMID: 6712192     DOI: 10.1002/ana.410150109

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  132 in total

1.  G3BP1 promotes DNA binding and activation of cGAS.

Authors:  Zhao-Shan Liu; Hong Cai; Wen Xue; Miao Wang; Tian Xia; Wan-Jin Li; Jia-Qing Xing; Ming Zhao; Yi-Jiao Huang; Shuai Chen; Sheng-Ming Wu; Xinzheng Wang; Xin Liu; Xue Pang; Zi-Yu Zhang; Tingting Li; Jiang Dai; Fangting Dong; Qing Xia; Ai-Ling Li; Tao Zhou; Zheng-Gang Liu; Xue-Min Zhang; Tao Li
Journal:  Nat Immunol       Date:  2018-12-03       Impact factor: 25.606

2.  Forget About "van der Knaap syndrome," forget about glycine.

Authors:  Marjo S Van der Knaap
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase.

Authors:  Rebecca D Powell; Paul J Holland; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Reconciling neuroimaging and clinical findings in Aicardi-Goutières syndrome: an autoimmune-mediated encephalopathy.

Authors:  G Ramantani; P Niggemann; T Bast; M A Lee-Kirsch
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-25       Impact factor: 3.825

Review 5.  [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].

Authors:  C Günther; F Schmidt; N König; M A Lee-Kirsch
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 6.  Intracellular Nucleic Acid Detection in Autoimmunity.

Authors:  John T Crowl; Elizabeth E Gray; Kathleen Pestal; Hannah E Volkman; Daniel B Stetson
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

Review 7.  Connections between antiviral defense and autoimmunity.

Authors:  Daniel B Stetson
Journal:  Curr Opin Immunol       Date:  2009-06-03       Impact factor: 7.486

8.  Recessive developmental delay, small stature, microcephaly and brain calcifications with locus on chromosome 2.

Authors:  Anna Rajab; Kimberly A Aldinger; Hisham Ali El-Shirbini; William B Dobyns; M Elizabeth Ross
Journal:  Am J Med Genet A       Date:  2009-02       Impact factor: 2.802

9.  Identification of two HIV inhibitors that also inhibit human RNaseH2.

Authors:  Junghwan Kim; Jaewan Yoon; MoonKyeong Ju; Yunmi Lee; Tae-Hee Kim; Junwon Kim; Peter Sommer; Zaesung No; Jonathan Cechetto; Sung-Jun Han
Journal:  Mol Cells       Date:  2013-09-02       Impact factor: 5.034

10.  The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.

Authors:  Markus J Hofer; Wen Li; Sue Ling Lim; Iain L Campbell
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.